Featured Article: Induction of heme oxygenase with hemin improves pericardial adipocyte morphology and function in obese Zucker rats by enhancing proteins of regeneration

Experimental Biology and Medicine - Tập 240 Số 1 - Trang 45-57 - 2015
Joseph Fomusi Ndisang1, Shuchita Tiwari1
1Department of Physiology, College of Medicine, University of Saskatchewan College of Medicine, Saskatoon, SK, Canada S7N 5E5

Tóm tắt

Oxidative stress and inflammation are implicated in tissue remodeling, hypertrophy, and organ malfunction. Since heme-oxygenase (HO) is a cytoprotective enzyme with effects against oxidative stress and inflammation, we investigated the effects of upregulating HO with hemin on adipocyte hypertrophy, proteins of repair/regeneration including beta-catenin, Oct3/4 and Pax2 as well as pro-fibrotic/remodeling proteins like osteopontin and transforming growth factor-beta (TGF-β) in pericardial adipose tissue from obese Zucker rats (ZRs). Treatment with hemin significantly reduced pericardial adipose tissue inflammation/oxidative stress, suppressed osteopontin and TGF-β, and attenuated pericardial adipocyte hypertrophy in obese ZRs. These were associated with enhanced expression of the stem/progenitor-cell marker cKit; the potentiation of several proteins of regeneration including beta-catenin, Oct3/4, Pax2; and improved pericardial adipocyte morphology. Interestingly, the amelioration of adipocyte hypertrophy in hemin-treated animals was accompanied by improved adipocyte function, evidenced by increased levels of pericardial adipose tissue adiponectin. Furthermore, hemin significantly reduced hypertriglyceridemia and hypercholesteromia in obese ZRs. The protective effects of hemin were accompanied by robust potentiation HO activity and the total antioxidant capacity, whereas the co-administration of hemin with the HO inhibitor, stannous mesoporphyrin abolished the effects of hemin. These data suggest that hemin improves pericardial adipocyte morphology and function by enhancing proteins of repair and regeneration, while concomitantly abating inflammatory/oxidative insults and suppressing extracellular-matrix/profibrotic and remodeling proteins. The reduction of hypertriglyceridemia, hypercholesteromia, pericardial adiposity, and pericardial adipocyte hypertrophy with corresponding improvement of adipocyte morphology/function in hemin-treated animals suggests that HO inducers may be explored for the design of novel remedies against cardiac complications arising from excessive adiposity.

Từ khóa


Tài liệu tham khảo

10.1055/s-0029-1192044

10.1111/dom.12130

10.1038/oby.2011.371

10.1126/science.7678183

10.2174/1573399810602040367

10.1038/nature05485

10.1161/CIRCULATIONAHA.107.743062

10.2337/dc10-1312

10.5551/jat.3939

10.1210/en.2008-0239

10.1210/en.2004-0851

10.1677/joe.1.06890

10.1152/ajpendo.90783.2008

10.1152/ajpendo.90241.2008

10.1016/j.cardfail.2009.02.003

10.1097/00004872-200306000-00011

10.1177/15353702-0322805-27

10.1097/00004872-200406000-00002

10.1124/pr.107.07104

10.1155/2010/359732

10.1210/en.2009-0471

10.1002/path.4286

10.1073/pnas.94.17.9308

10.1016/j.arr.2007.09.001

10.1371/journal.pone.0013959

10.1007/s10741-010-9158-6

10.1016/0273-2300(92)90088-Q

10.1161/01.HYP.0000128621.68160.dd

10.1210/en.2010-1328

10.4049/jimmunol.1101342

10.1161/HYPERTENSIONAHA.111.190512

10.1371/journal.pone.0064752

10.1042/CS20120644

10.1038/ijo.2013.116

10.1124/jpet.112.200808

10.1371/journal.pone.0079270

10.1161/HYPERTENSIONAHA.108.114801

10.1152/ajprenal.00510.2007

10.1093/ajh/hpt082

10.1371/journal.pone.0087936

10.1016/j.freeradbiomed.2012.10.529

Reaven GM, 2005, Panminerva Med, 47, 201

10.1186/1476-7120-7-56

10.1016/j.amjcard.2011.03.049

10.1016/j.redox.2013.12.009

10.1371/journal.pone.0061380

10.3109/10715762.2013.772604

10.1161/01.CIR.95.11.2492

10.1055/s-2008-1078710

10.1097/TA.0b013e318069178a

10.1096/fj.13-228817

10.1007/s00125-013-3015-9

10.1152/ajprenal.00374.2009

10.1016/j.jacc.2011.01.048

10.1371/journal.pone.0070663

10.1159/000337591

10.1007/s12015-010-9215-5

10.3727/096368912X637055

10.1161/HYPERTENSIONAHA.110.149963

10.1074/jbc.M005955200

10.1007/s00125-013-2885-1

10.1155/2013/253657

10.1091/mbc.E08-10-1005